
|Articles|February 1, 2002
Skin substitute may improve post-Mohs appearance
Chicago - A single application of tissue-engineered, bilayeredskin substitute (Human Skin Substitute, Apligraf) to full-thickness woundscreated from Mohs micrographic or excisional surgery treatment of skin cancersresults in scars slightly more favorable than those healed by secondary-intentionhealing, according to single center study results.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
4
Introducing Dermatology Times NP/PA Connect
5











